financetom
Business
financetom
/
Business
/
Nauticus Robotics Begins Testing of Underwater Vehicle
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nauticus Robotics Begins Testing of Underwater Vehicle
Sep 22, 2024 7:20 PM

04:32 AM EDT, 09/18/2024 (MT Newswires) -- Nauticus Robotics ( KITT ) said late Tuesday that it began a second round of testing of its underwater vehicle, Aquanaut Mark 2, in the Gulf of Mexico.

The testing is meant to certify the vehicle for depths of over 2,000 meters, the company said.

The tests are being conducted at a decommissioned oil and gas field off the coast of Louisiana to show commercial applications. The Aquanaut Mark 2 can image subsea structures such as trees and pipelines.

Price: 1.6700, Change: +0.12, Percent Change: +7.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cypherpunk Technologies' Q3 net loss narrows
Cypherpunk Technologies' Q3 net loss narrows
Nov 12, 2025
Overview * Cypherpunk Technologies reports Q3 net loss of $3.3 mln, down from $18.2 mln last year * Company acquires 203,775 ZEC for $50 mln as part of digital asset strategy * Closed $58.88 mln private placement led by Winklevoss Capital for digital asset strategy Outlook * Company did not provide specific financial guidance for future quarters or year Result...
Coya Therapeutics' Q3 net loss narrows
Coya Therapeutics' Q3 net loss narrows
Nov 12, 2025
Overview * Coya Therapeutics ( COYA ) Q3 net loss narrows to $2.1 mln from $4.0 mln last year * Company reports $3.6 mln collaboration revenue due to IND approval milestone * Coya completes $23 mln public offering, extending cash runway into 2H 2027 Outlook * Company expects to receive $4.2 mln milestone payment upon first patient dosing in ALS...
Corbus Pharma Q3 net loss widens to $23.3 mln
Corbus Pharma Q3 net loss widens to $23.3 mln
Nov 12, 2025
Overview * Corbus Pharmaceuticals ( CRBP ) Q3 net loss widens to $23.3 mln, driven by clinical development costs * Company completed $75 mln public offering, extending cash runway into 2028 * CRB-701 clinical data shows promising ORR in HNSCC, cervical, and bladder cancers Outlook * Company plans to meet FDA in Q1 2026 for CRB-701 data review * Corbus...
Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus
Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus
Nov 12, 2025
Overview * LightInTheBox ( LITB ) Q3 net income rises to $2.8 mln from $0.3 mln last year * Company Q3 revenue declines 3% yr/yr, reflecting focus on margin preservation * Gross margin improves to 66.9% from 61.1% last year, driven by high-margin products Outlook * LightInTheBox ( LITB ) expects overall revenue growth in 2026 * Company plans broader...
Copyright 2023-2026 - www.financetom.com All Rights Reserved